C219107Level 6
Marker Therapeutics
**Semantic type:** Organization
**Definition:** A biotech company working on the development and commercialization of multi-antigen recognizing T-cell-based immunotherapies for patients with a wide range of blood cancers and solid tumors.
GET
/api/v1/systems/nci_thesaurus/nodes/C219107Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.